Industry n/a · SIC —

Avricore Health Inc.

AVCRF

Watch

Latest revenue

as of

Latest net income

as of

Net margin

as of

8.7
of 10

ActaClear Score

Strong
#553 of 4096 in industry
new
Profitability·25%
Growth·15%
Value·20%
8.4
Quality·20%
Momentum·20%
9.0

Computed from 5 years of SEC fundamentals + latest market data, ranked within industry (4096 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 6, 2026.

Community sentiment

Where do you think AVCRF is heading?

1 month
6 months
12 months
5 years
Sign in free to vote and see community sentiment

Price · 5Y

-20.5% / yr 40.2 pts / yr vs S&P 500 59.7% total
Compare:

Live market

delayed ≤15 min
$0.05
45.08%
Market cap
$4.6M
Enterprise value
$4.6M
P/E (trailing)
Forward P/E
P/B
Dividend yield
0.0%
52-wk high
$0.08
52-wk low
$0.02
Beta
Shares out
101.3M

5-year trend

No quarterly data ingested yet for this company.

About AVCRF

Business description and risk factors will appear here once AVCRF's latest filing is fully ingested.

Earnings tracker

Not enough quarterly history for AVCRF yet to draw an earnings tracker.

Industry trend

Industry · SIC

No data yet for industry average

Your notes

Keep private notes on AVCRF — thesis, target price, catalysts to watch.

Visible only to you. Never shared. Never used to train AI.

Sign in to write a note

Insider activity

No insider transactions on file for AVCRF in the last 12 months.

Source: SEC Form 4 filings. Backfill runs nightly.

Who owns AVCRF

No institutional holdings on file for AVCRF yet.

Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).

Top questions investors are asking

Coming once AVCRF's latest filing finishes processing.

Investor sentiment
No votes yet
0 this week · 0 total

Sign in to vote. Votes use 7-day half-life decay.

What matters about AVCRF?
Tap any that apply. Aggregates show what other investors flag.

Sign in to tap. 7-day half-life decay.